QIAGEN informatics solutions chosen to support Genomics England’s bold five million genomes in five years project
Hilden, Germany, and London, United Kingdom, February 4, 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that Genomics England have selected QIAGEN’s QCI (QIAGEN Clinical Insights) portfolio offering on behalf of the NHS in England to support the UK’s program to sequence, analysis and interpret 5 million genomes over the next 5... Read more